| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:obln | nasdaq:obln Shareholders | 13F-HR/A | 0000948046-21-000195 | Sep 30th, 2018 12:00AM | Dec 21st, 2021 12:00AM | Dec 21st, 2021 12:00AM | DEUTSCHE BANK AG\ | 948046 | OBALON THERAPEUTICS INC | COM | 67424L100 | 5 | 1800 | SH | DFND | 10 | 1800 | 0 | 0 | May 5th, 2022 07:59AM | May 5th, 2022 07:59AM | Obalon Therapeutics | |||
| nasdaq:obln | nasdaq:obln Shareholders | 13F-HR | 0001566475-18-000010 | Sep 30th, 2018 12:00AM | Nov 15th, 2018 12:00AM | Nov 15th, 2018 12:00AM | HPM Partners LLC | 1566475 | OBALON THERAPEUTICS INC | COM | 67424L100 | 56 | 20686 | SH | SOLE | 20686 | 0 | 0 | Dec 8th, 2021 01:47PM | Dec 8th, 2021 01:47PM | Obalon Therapeutics | ||||
| nasdaq:obln | nasdaq:obln Shareholders | 13F-HR | 0001104659-18-068290 | Sep 30th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Nov 14th, 2018 12:00AM | FRED ALGER MANAGEMENT INC | 3520 | OBALON THERAPEUTICS INC | Common | 67424L100 | 126 | 46795 | SH | SOLE | 46795 | 0 | 0 | Dec 8th, 2021 01:20PM | Dec 8th, 2021 01:20PM | Obalon Therapeutics | ||||
| nasdaq:obln | nasdaq:obln Shareholders | 13F-HR | 0001085146-18-002670 | Sep 30th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Nov 14th, 2018 12:00AM | JACOBS LEVY EQUITY MANAGEMENT, INC | 884414 | OBALON THERAPEUTICS INC | COM | 67424L100 | 30 | 11100 | SH | SOLE | 11100 | 0 | 0 | Dec 8th, 2021 01:18PM | Dec 8th, 2021 01:18PM | Obalon Therapeutics | ||||
| nasdaq:obln | nasdaq:obln Shareholders | 13F-HR | 0001725547-18-000027 | Sep 30th, 2018 12:00AM | Nov 13th, 2018 12:00AM | Nov 13th, 2018 12:00AM | HoyleCohen, LLC | 1559077 | OBALON THERAPEUTICS INC | COM | 67424L100 | 310 | 114650 | SH | SOLE | 0 | 0 | 114650 | Dec 8th, 2021 12:54PM | Dec 8th, 2021 12:54PM | Obalon Therapeutics | ||||
| nasdaq:obln | nasdaq:obln Shareholders | 13F-HR | 0001567619-18-005717 | Sep 30th, 2018 12:00AM | Nov 13th, 2018 12:00AM | Nov 13th, 2018 12:00AM | Spark Investment Management LLC | 1554871 | OBALON THERAPEUTICS INC | COM | 67424L100 | 49 | 18300 | SH | SOLE | 18300 | 0 | 0 | Dec 8th, 2021 12:52PM | Dec 8th, 2021 12:52PM | Obalon Therapeutics | ||||
| nasdaq:obln | nasdaq:obln Shareholders | 13F-HR | 0001095449-18-000097 | Sep 30th, 2018 12:00AM | Nov 13th, 2018 12:00AM | Nov 13th, 2018 12:00AM | Tamarack Advisers, LP | 1661462 | OBALON THERAPEUTICS INC | Equity | 67424L100 | 5670 | 2100000 | SH | SOLE | 2100000 | 0 | 0 | Dec 8th, 2021 12:47PM | Dec 8th, 2021 12:47PM | Obalon Therapeutics | ||||
| nasdaq:obln | nasdaq:obln Shareholders | 13F-HR | 0001649107-18-000006 | Sep 30th, 2018 12:00AM | Nov 9th, 2018 12:00AM | Nov 9th, 2018 12:00AM | Moisand Fitzgerald Tamayo, LLC | 1649107 | OBALON THERAPEUTICS INC | COM | 67424L100 | 302 | 6765 | PRN | SOLE | 6765 | 0 | 0 | Dec 8th, 2021 12:20PM | Dec 8th, 2021 12:20PM | Obalon Therapeutics | ||||
| nasdaq:obln | nasdaq:obln Shareholders | 13F-HR | 0001398344-18-016181 | Sep 30th, 2018 12:00AM | Nov 8th, 2018 12:00AM | Nov 8th, 2018 12:00AM | Granite Investment Partners, LLC | 1542266 | OBALON THERAPEUTICS INC | COM | 67424L100 | 184 | 68023 | SH | DFND | 1 | 68023 | 0 | 0 | Dec 8th, 2021 11:49AM | Dec 8th, 2021 11:49AM | Obalon Therapeutics | |||
| nasdaq:obln | nasdaq:obln Shareholders | 13F-HR | 0001398344-18-016181 | Sep 30th, 2018 12:00AM | Nov 8th, 2018 12:00AM | Nov 8th, 2018 12:00AM | Granite Investment Partners, LLC | 1542266 | OBALON THERAPEUTICS INC | COM | 67424L100 | 26 | 9488 | SH | SOLE | 9488 | 0 | 0 | Dec 8th, 2021 11:49AM | Dec 8th, 2021 11:49AM | Obalon Therapeutics |